| __timestamp | Bausch Health Companies Inc. | Viatris Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 246000000 | 581800000 |
| Thursday, January 1, 2015 | 582800000 | 671900000 |
| Friday, January 1, 2016 | 455000000 | 876700000 |
| Sunday, January 1, 2017 | 366000000 | 857900000 |
| Monday, January 1, 2018 | 414000000 | 822200000 |
| Tuesday, January 1, 2019 | 471000000 | 778200000 |
| Wednesday, January 1, 2020 | 452000000 | 512600000 |
| Friday, January 1, 2021 | 465000000 | 681000000 |
| Saturday, January 1, 2022 | 529000000 | 662200000 |
| Sunday, January 1, 2023 | 604000000 | 910700000 |
Unleashing insights
In the competitive landscape of pharmaceuticals, strategic investment in research and development (R&D) is crucial for innovation and growth. Over the past decade, Viatris Inc. and Bausch Health Companies Inc. have demonstrated distinct approaches to R&D spending. From 2014 to 2023, Viatris consistently outpaced Bausch Health, with R&D expenses peaking at 910 million in 2023, a 56% increase from 2014. In contrast, Bausch Health's R&D spending grew by 145% over the same period, reaching 604 million in 2023. This divergence highlights Viatris's aggressive investment strategy, while Bausch Health shows a steady, albeit slower, commitment to innovation. As the pharmaceutical industry evolves, these spending patterns may influence each company's ability to bring new products to market and maintain competitive advantage.
Research and Development Investment: Sanofi vs Bausch Health Companies Inc.
Research and Development: Comparing Key Metrics for argenx SE and Bausch Health Companies Inc.
Who Prioritizes Innovation? R&D Spending Compared for United Therapeutics Corporation and Bausch Health Companies Inc.
Comparing Innovation Spending: Incyte Corporation and Viatris Inc.
Research and Development Investment: Viatris Inc. vs Corcept Therapeutics Incorporated
Who Prioritizes Innovation? R&D Spending Compared for Viatris Inc. and ACADIA Pharmaceuticals Inc.
Who Prioritizes Innovation? R&D Spending Compared for Viatris Inc. and Supernus Pharmaceuticals, Inc.
Viatris Inc. or Amphastar Pharmaceuticals, Inc.: Who Invests More in Innovation?
Analyzing R&D Budgets: Veracyte, Inc. vs Bausch Health Companies Inc.
R&D Insights: How ACADIA Pharmaceuticals Inc. and Bausch Health Companies Inc. Allocate Funds
Research and Development Expenses Breakdown: Bausch Health Companies Inc. vs Mesoblast Limited
Analyzing R&D Budgets: Bausch Health Companies Inc. vs Ligand Pharmaceuticals Incorporated